Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches.

Yin, Hanlin; Li, Rui; Lu, Liangjing; Yan, Qingran

Yin, Hanlin; Li, Rui; Lu, Liangjing; Yan, Qingran.

Afiliação

Yin H; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 145 Shandong Middle Road, Shanghai, 200001, China.
Li R; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 145 Shandong Middle Road, Shanghai, 200001, China.
Lu L; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 145 Shandong Middle Road, Shanghai, 200001, China. lu_liangjing@163.com.
Yan Q; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 145 Shandong Middle Road, Shanghai, 200001, China. yanqingran@163.com.

Curr Rheumatol Rep ; 22(11): 77, 2020 09 21.

Article em En | MEDLINE | ID: mdl-32959073

Assuntos

Escleroderma Sistêmico; Animais; Epigênese Genética; Fibrose; Código das Histonas; Humanos; Terapia de Alvo Molecular; Escleroderma Sistêmico/tratamento farmacológico; Escleroderma Sistêmico/genética

Palavras-chave

Epigenetics; Fibrosis; Immunity; Metabolism; Systemic sclerosis; Therapeutic targets

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Curr Rheumatol Rep Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google